The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Niclosamide a new chemotherapy agent? Pharmacokinetics of the potential anticancer drug in a patient cohort of the NIKOLO trial.
 
Susen Burock
No Relationships to Disclose
 
Severin Daum
No Relationships to Disclose
 
Hanno Tröger
No Relationships to Disclose
 
Theo Daniel Kim
No Relationships to Disclose
 
Sandrine Krüger
No Relationships to Disclose
 
Damian Tobias Rieke
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alacris Theranostics
 
Sebastian Ochsenreither
Consulting or Advisory Role - Bristol-Myers Squibb (I); CureVac; Glenmark; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Kerstin Welter
No Relationships to Disclose
 
Pia Herrmann
No Relationships to Disclose
 
Arthur Sleegers
No Relationships to Disclose
 
Wolfgang Walther
No Relationships to Disclose
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Merck Serono; MSD Oncology
 
Ulrike Stein
No Relationships to Disclose